2.1 General Features & Classification of Viruses
Introduction
- Viruses are obligate intracellular parasites — they have no independent metabolism and cannot replicate outside a living host cell.
- Each virus carries only one type of nucleic acid — either DNA or RNA, never both — unlike cellular organisms.
- They are far smaller than bacteria (typically 20–300 nm) and lack ribosomes, so they must hijack the host cell's machinery to make new viral proteins.
Basic Structural Components
- Genome: DNA or RNA, single- or double-stranded, linear or circular, segmented in some families.
- Capsid: protein shell built from repeating subunits (capsomeres); protects the genome and mediates attachment in non-enveloped viruses. Common symmetries: icosahedral (spherical-looking) or helical (rod-like).
- Nucleocapsid: genome + capsid together.
- Envelope: a lipid bilayer some viruses acquire from the host cell membrane as they bud out; studded with viral glycoprotein spikes used for attachment.
Enveloped vs. Non-Enveloped Virus
Classification Basics
| Criterion | Category A | Category B |
|---|---|---|
| Nucleic acid | DNA viruses | RNA viruses |
| Envelope | Enveloped | Non-enveloped (naked) |
| Capsid symmetry | Icosahedral | Helical |
| Genome strandedness | Single-stranded | Double-stranded |
Clinical Correlation
Concept: The lipid envelope is fragile and easily disrupted by soap, alcohol, and detergents — which is exactly why hand washing and alcohol-based sanitizers are so effective against enveloped viruses like influenza, HIV, and coronaviruses.
Contrast: Non-enveloped viruses (e.g., norovirus, poliovirus) lack this vulnerable lipid layer and are markedly more resistant to alcohol-based disinfectants — outbreaks of norovirus are classically controlled with bleach, not hand sanitizer alone.
2.2 Viral Replication Cycle
The Six Steps
- 1Attachment — viral surface proteins bind a specific host cell receptor.
- 2Penetration — the virus enters the cell (membrane fusion for enveloped viruses, or endocytosis).
- 3Uncoating — the capsid is removed, releasing the viral genome into the cell.
- 4Biosynthesis — the host machinery is hijacked to transcribe and translate viral genes and replicate the genome.
- 5Assembly — new capsids and genomes are packaged into complete virions.
- 6Release — new virions exit by cell lysis (typically non-enveloped viruses) or budding through the membrane (enveloped viruses, which acquire their envelope this way).
Lysis vs. Budding Release
| Feature | Lysis | Budding |
|---|---|---|
| Typical virus type | Non-enveloped | Enveloped |
| Effect on host cell | Cell destroyed, dies immediately | Cell may survive, releasing virus gradually |
| Example | Poliovirus | Influenza, HIV |
Clinical Correlation
Antiviral drugs are often designed to block a single, specific step of this cycle. For example, enfuvirtide blocks HIV's membrane fusion (penetration step), while neuraminidase inhibitors like oseltamivir block influenza's release step by preventing new virions from budding free of the cell surface.
2.3 Bacteriophages
Introduction
- Bacteriophages ("phages") are viruses that infect bacteria specifically, following the same general replication logic as other viruses.
- They follow one of two life cycles depending on the phage type and conditions: lytic or lysogenic.
Lytic vs. Lysogenic Cycle
| Feature | Lytic Cycle | Lysogenic Cycle |
|---|---|---|
| Outcome | Immediate replication and cell lysis | Phage DNA integrates into host chromosome (prophage) |
| Host cell fate | Destroyed | Survives, divides normally, passes prophage to daughter cells |
| Trigger to become lytic | — | Stress (e.g., UV light) can induce excision and a switch to the lytic cycle |
Clinical Correlation
Concept: While integrated as a prophage, a lysogenic phage can carry bacterial toxin genes that the bacterium expresses as its own — this is exactly how diphtheria toxin (Corynebacterium diphtheriae) and cholera toxin (Vibrio cholerae) genes were originally acquired, a process called lysogenic (phage) conversion, covered in Chapter 1's bacterial genetics.
2.4 Viral Genetics & Variation
Sources of Viral Variation
- Mutation: RNA viruses mutate especially fast because RNA polymerases lack proofreading ability, unlike DNA polymerases.
- Reassortment: when a cell is co-infected by two different strains of a segmented-genome virus, entire gene segments can mix into new combinations.
- Recombination: exchange of genetic material between two viral genomes during co-infection.
Antigenic Drift vs. Antigenic Shift
| Feature | Antigenic Drift | Antigenic Shift |
|---|---|---|
| Mechanism | Gradual point mutations | Sudden reassortment of gene segments |
| Magnitude of change | Small, incremental | Large, abrupt |
| Clinical consequence | Seasonal flu epidemics | Influenza pandemics (novel strain, little population immunity) |
Clinical Correlation
Influenza's segmented RNA genome and error-prone polymerase make it drift constantly, so last year's antibodies may no longer recognize this year's circulating strain — this is precisely why the seasonal influenza vaccine is reformulated annually to match predicted circulating strains.
2.5 Mechanisms of Action of Antiviral Agents
Classification by Target Step
| Target Step | Drug Class | Example Agents |
|---|---|---|
| Attachment/Entry | Fusion/entry inhibitors | Enfuvirtide, maraviroc (HIV) |
| Uncoating | M2 ion channel blockers | Amantadine (older influenza drug) |
| Genome replication | Nucleoside/nucleotide analogs | Acyclovir, tenofovir, remdesivir |
| Genome replication | Reverse transcriptase inhibitors | Zidovudine, efavirenz |
| Protein processing | Protease inhibitors | Ritonavir, lopinavir |
| Release | Neuraminidase inhibitors | Oseltamivir, zanamivir |
Clinical Correlation
Concept: HIV treatment combines drugs from different mechanistic classes (e.g., a reverse transcriptase inhibitor + a protease inhibitor) rather than relying on one drug alone. Hitting multiple independent steps of the replication cycle simultaneously makes it far harder for the virus to develop resistance to the entire regimen at once — the same logic behind multi-drug tuberculosis therapy in bacteriology.
2.6 Antiviral Resistance
Common Resistance Mechanisms
- 1Target enzyme mutation — mutations in reverse transcriptase or protease reduce drug binding (classic in HIV under selective drug pressure).
- 2Reduced drug activation — some antivirals are prodrugs requiring a viral enzyme to become active; loss of that enzyme's activity blocks activation (e.g., acyclovir requires viral thymidine kinase).
- 3Rapid mutation rate — RNA viruses' error-prone replication generates resistant variants quickly under drug pressure, similar in logic to bacterial antibiotic resistance selection.
Clinical Correlation
Mechanism: Acyclovir must first be phosphorylated by the herpesvirus's own thymidine kinase to become active. Immunocompromised patients on long-term acyclovir can select for HSV strains with a mutated or absent thymidine kinase — these strains can no longer activate the drug and become clinically resistant, usually requiring a switch to foscarnet, which does not require viral activation.
2.7 Herpesviruses
Introduction
- Herpesviridae are large, enveloped, double-stranded DNA viruses.
- Their hallmark biological feature is latency — after primary infection, the virus persists silently in specific host cells for life and can periodically reactivate.
Key Human Herpesviruses
| Virus | Site of Latency | Classic Disease |
|---|---|---|
| HSV-1 | Trigeminal ganglion | Oral herpes (cold sores), keratitis, encephalitis |
| HSV-2 | Sacral ganglion | Genital herpes |
| Varicella-zoster (VZV) | Dorsal root ganglia | Chickenpox (primary); shingles (reactivation) |
| Epstein-Barr virus (EBV) | B lymphocytes | Infectious mononucleosis; linked to Burkitt lymphoma |
| Cytomegalovirus (CMV) | Monocytes, lymphocytes | Mononucleosis-like illness; congenital infection; disease in immunosuppressed patients |
Clinical Correlation
Latent herpesviruses reactivate under stress, UV light exposure, fever, or immunosuppression — this is why cold sores classically recur during illness or sun exposure, and why shingles (VZV reactivation) appears decades after childhood chickenpox, often when cell-mediated immunity naturally declines with age or is suppressed by disease/medication.
2.8 Hepatitis Viruses
Overview
| Virus | Genome | Transmission |
|---|---|---|
| Hepatitis A (HAV) | RNA | Fecal-oral (contaminated food/water) |
| Hepatitis B (HBV) | DNA | Blood, sexual contact, perinatal |
| Hepatitis C (HCV) | RNA | Blood (needles, transfusions) |
| Hepatitis D (HDV) | RNA (defective — needs HBV) | Blood, sexual contact (only with HBV co-infection) |
| Hepatitis E (HEV) | RNA | Fecal-oral; severe in pregnancy |
Chronicity Risk
- 1HAV and HEV — acute infection only; do not become chronic.
- 2HBV — usually resolves in healthy adults, but can become chronic, especially if acquired perinatally or in early childhood.
- 3HCV — the highest chronicity rate of all hepatitis viruses, frequently progressing silently toward cirrhosis.
Clinical Correlation
HBsAg positive = currently infected (acute or chronic). Anti-HBs positive (alone) = immune, either from past infection or vaccination. Anti-HBc IgM positive = recent acute infection, useful during the "window period" when HBsAg has cleared but anti-HBs hasn't yet appeared. For Hepatitis C, an anti-HCV antibody-positive result only indicates past exposure — a follow-up HCV RNA test is required to confirm whether the infection is currently active, since the antibody alone cannot distinguish cleared infection from ongoing chronic infection.
2.9 HIV & Retroviruses
Structure & Replication
- HIV is an enveloped retrovirus — its RNA genome is reverse-transcribed into DNA by the viral enzyme reverse transcriptase.
- The resulting DNA copy integrates into the host cell's chromosome (via integrase), becoming a permanent provirus — this is why HIV infection cannot currently be cured, only controlled.
- HIV primarily infects CD4+ T helper cells, using CD4 plus a co-receptor (CCR5 or CXCR4) for entry.
Disease Progression
| Stage | CD4 Count | Clinical Picture |
|---|---|---|
| Acute infection | Transient drop, then recovers | Flu-like illness (fever, rash, lymphadenopathy) 2–4 weeks post-exposure |
| Chronic/latent phase | Gradual decline over years | Often asymptomatic |
| AIDS | < 200 cells/µL | Opportunistic infections (e.g., Pneumocystis pneumonia, disseminated M. avium), AIDS-defining cancers |
Clinical Correlation
Modern 4th-generation HIV tests detect both antibodies and the p24 antigen, shortening the "window period" (the time after exposure before a test can reliably detect infection) to roughly 2–4 weeks, compared to older antibody-only tests that could take up to 3 months to turn positive — an important consideration when counseling a patient about when to retest after a possible exposure.